Literature DB >> 6616162

Risk of gastric cancer after Billroth II resection for duodenal ulcer.

A B Fischer, N Graem, O M Jensen.   

Abstract

In a follow-up study of 1000 patients, who were subjected to Billroth II resection for duodenal ulcer, the incidence and mortality of gastric carcinoma in a 22-30 year follow-up period were determined. Among the 423 survivors traced, 196 underwent gastroscopy and biopsy but carcinomas of the gastric remnant were not seen. Thus the prevalence was 0, not significantly different from the expected prevalence of 0.3. From all 1000 patients only 13 cases of gastric carcinoma were identified. This is not significantly different from the expected number of 10.6 calculated by the life table method and indirectly standardized for age, sex, place of residence and time. Even more than 15 years after operation the gastric cancer risk was only slightly increased (observed/expected = 7/4.8 +/- 1.48), but this was not significant statistically. Of 522 deaths 13 were due to gastric carcinoma, which was not significantly different from the expected number of 10.2. These epidemiological data show that individuals subjected to Billroth II resection for duodenal ulcer hardly have a higher risk of gastric carcinoma than the general population within the first decades after operation. Thus proplylactic endoscopical monitoring will be unrewarding.

Entities:  

Mesh:

Year:  1983        PMID: 6616162     DOI: 10.1002/bjs.1800700915

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  20 in total

Review 1.  Controversy surrounding 'mini' gastric bypass.

Authors:  Kamal K Mahawar; William R J Carr; Shlok Balupuri; Peter K Small
Journal:  Obes Surg       Date:  2014-02       Impact factor: 4.129

2.  Gastric cancer in primary care: how hard should you look?

Authors:  E M Guirguis
Journal:  Can Fam Physician       Date:  1989-02       Impact factor: 3.275

3.  Current state of gastric stump carcinoma in Japan: based on the results of a nationwide survey.

Authors:  Nobuhiko Tanigawa; Eiji Nomura; Sang-Woong Lee; Michio Kaminishi; Mitsugu Sugiyama; Takashi Aikou; Masaki Kitajima
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

4.  Exposure to bile acids and bacteria over 24 hours following partial gastrectomy, vagotomy, and pyloroplasty.

Authors:  V A Poxon; D L Morris; D J Youngs; E C Albutt; M R Keighley
Journal:  World J Surg       Date:  1986-12       Impact factor: 3.352

Review 5.  Assessing the safety of drugs for the long-term treatment of peptic ulcers.

Authors:  K G Wormsley
Journal:  Gut       Date:  1984-12       Impact factor: 23.059

6.  Malignant lymphoma of the gastric stump developing 25 years after a distal gastrectomy for benign gastric disease: report of a case.

Authors:  K Kondo; Y Yokoyama; I Yokoyama; M Kikuchi; Y Kuno; M Kataoka; T Ichihara; M Horisawa; S Akiyama; K Ito; H Takagi
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

7.  Vagotomy or gastrectomy for elective treatment of benign gastric ulceration?

Authors:  M J Greenall; T Lehnert
Journal:  Dig Dis Sci       Date:  1985-04       Impact factor: 3.199

8.  Primary results of laparoscopic mini-gastric bypass in a French obesity-surgery specialized university hospital.

Authors:  Ghassan Chakhtoura; Franck Zinzindohoué; Yassine Ghanem; Ivan Ruseykin; Jean-Christophe Dutranoy; Jean-Marc Chevallier
Journal:  Obes Surg       Date:  2008-06-20       Impact factor: 4.129

9.  Management of gastric remnant carcinoma based on the results of a 15-year endoscopic screening program.

Authors:  F L Greene
Journal:  Ann Surg       Date:  1996-06       Impact factor: 12.969

10.  Death from malignant disease after surgery for duodenal ulcer.

Authors:  I M Macintyre; F O'Brien
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.